Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2089300
Max Phase: Preclinical
Molecular Formula: C37H43ClN4O4S
Molecular Weight: 675.30
Molecule Type: Small molecule
Associated Items:
ID: ALA2089300
Max Phase: Preclinical
Molecular Formula: C37H43ClN4O4S
Molecular Weight: 675.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)NC12CC3CC(CC(CS(=O)(=O)NC(=O)c4ccc(N5CCN(Cc6ccccc6-c6ccc(Cl)cc6)CC5)cc4)(C3)C1)C2
Standard InChI: InChI=1S/C37H43ClN4O4S/c1-26(43)39-37-21-27-18-28(22-37)20-36(19-27,24-37)25-47(45,46)40-35(44)30-8-12-33(13-9-30)42-16-14-41(15-17-42)23-31-4-2-3-5-34(31)29-6-10-32(38)11-7-29/h2-13,27-28H,14-25H2,1H3,(H,39,43)(H,40,44)
Standard InChI Key: JTSBQQURLADPGL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 675.30 | Molecular Weight (Monoisotopic): 674.2694 | AlogP: 5.86 | #Rotatable Bonds: 9 |
Polar Surface Area: 98.82 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.07 | CX Basic pKa: 8.35 | CX LogP: 3.87 | CX LogD: 3.93 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.30 | Np Likeness Score: -1.12 |
1. Yusuff N, Doré M, Joud C, Visser M, Springer C, Xie X, Herlihy K, Porter D, Touré BB.. (2012) Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction., 3 (7): [PMID:24900514] [10.1021/ml300095a] |
Source(1):